Construction of a Bcl-2-shRNA expression vector and its effect on the mitochondrial apoptosis pathway in SW982 cells

Zhang,Weidong; Xue,Xinjie; Fu,Teng

doi:10.3892/ijmm.2017.3156

Construction of a Bcl-2-shRNA expression vector and its effect on the mitochondrial apoptosis pathway in SW982 cells

Authors:
- Weidong Zhang
- Xinjie Xue
- Teng Fu
View Affiliations

Affiliations: Guangming Hospital of Traditional Chinese Medicine, Shanghai 201300, P.R. China, University of Kansas, Lawrence, KS 66045, USA
Published online on: September 27, 2017 https://doi.org/10.3892/ijmm.2017.3156
Pages: 1914-1920

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Apoptosis is considered to serve an important role in the pathogenesis of rheumatoid arthritis. The aim of the present study was to construct Bcl-2-short hairpin (sh)RNA expression vectors and transfect them into human synovial sarcoma SW982 cells, in order to screen for an effective interference sequence and analyze the effects of this interference on the expression levels of Bcl-2 and other molecules associated with the mitochondrial apoptosis pathway. Three different shRNAs (Bcl-2-sh1, 2 and 3) were designed according to the human Bcl-2 mRNA target sequence and were transformed into competent DH5α Escherichia coli cells following the construction of an expression vector, which was then transfected into SW982 cells. SW982 cells were grouped into a control group (transfected with a negative control shRNA), and Bcl-2-sh1, Bcl-2-sh2 and Bcl-2-sh3 groups (transfected with Bcl-2-sh1, 2 and 3, respectively). The expression levels of Bcl-2 mRNA were detected using reverse transcription-quantitative PCR (RT-qPCR). Bcl-2-sh1 was identified as the most effective shRNA sequence for interference, and was used for subsequent experiments. The mRNA and protein expression levels of Bcl-2, Bax, CytC and Caspase-3 were detected in SW982 cells by RT-qPCR and western blotting at various time-points (48 and 72 h) following transfection with Bcl-2-sh1, in order to observe the effectiveness of this interference. Compared with the control group, the expression levels of Bcl-2 were decreased, while those of Bax, CytC and Caspase-3 were increased in Bcl-2-sh1-transfected cells (P<0.01). The interference effect was greater at 48 h than at 72 h. In summary, an effective shRNA sequence (Bcl-2-sh1) targeting the Bcl-2 gene was identified from three candidates, and was demonstrated to significantly interfere with the expression of Bcl-2, Bax, CytC and Caspase-3 when transfected into SW982 cells. The interference effect of Bcl-2-sh1 was more pronounced at 48 h than at 72 h post-transfection.

View Figures

View References

1	Macintyre NJ, Muller ME, Webber CE and Adachi JD: The relationship between radial bone properties and disease activity and physical function in individuals with rheumatoid arthritis. Physiother Can. 64:284–291. 2012. View Article : Google Scholar :
2	Navalho M, Resende C, Rodrigues AM, Pereira da Silva JA, Fonseca JE, Campos J and Canhão H: Bilateral evaluation of the hand and wrist in untreated early inflammatory arthritis: A comparative study of ultrasonography and magnetic resonance imaging. J Rheumatol. 40:1282–1292. 2013. View Article : Google Scholar : PubMed/NCBI
3	Krabben A, Abhishek A, Britsemmer K, Filer A, Huizinga TW, Raza K, van Schaardenburg DJ and van der Helm-van Mil AH: Risk of rheumatoid arthritis development in patients with unclassified arthritis according to the 2010 ACR/EULAR criteria for rheumatoid arthritis. Rheumatology (Oxford). 52:1265–1270. 2013. View Article : Google Scholar
4	Shin SY, Katz P, Wallhagen M and Julian L: Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken). 64:1144–1150. 2012.
5	Li R, Yan G, Li Q, Sun H, Hu Y, Sun J and Xu B: MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H₂O₂)-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS One. 7:449072012. View Article : Google Scholar
6	Mane SD, Thoh M, Sharma D, Sandur SK and Naidu KA: Ascorbyl stearate promotes apoptosis through intrinsic mitochondrial pathway in HeLa cancer cells. Anticancer Res. 36:6409–6417. 2016. View Article : Google Scholar : PubMed/NCBI
7	Zhang WD, Zhang Z, Zhang H, et al: Oxygen free radicals and mitochondrial signaling in oligospermia and asthenospermia. Mol Med Rep. 10:1875–1880. 2014. View Article : Google Scholar : PubMed/NCBI
8	Yan C, Kong D, Ge D, Zhang Y, Zhang X, Su C and Cao X: Mitomycin C induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via a mitochondrial-mediated pathway. Cell Physiol Biochem. 35:1125–1136. 2015. View Article : Google Scholar : PubMed/NCBI
9	Liu L, Liu Y, Zhang X, Chen M, Wu H, Lin M, Zhan Y, Zhuang C, Lin J, Li J, et al: Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer. Oncotarget. 7:25125–25134. 2016. View Article : Google Scholar : PubMed/NCBI
10	Li G, Zhang L, Liu J, Xiao T, Liu G, Wang J and Hou M: shRNA-mediated RPS15A silencing inhibits U937 acute myeloid leukemia cell proliferation and enhances apoptosis. Mol Med Rep. 13:4400–4406. 2016. View Article : Google Scholar : PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
12	Liu H, Yang Y, Cai X, Gao Y, Du J and Chen S: The effects of arctigenin on human rheumatoid arthritis fibroblast-like synoviocytes. Pharm Biol. 53:1118–1123. 2015. View Article : Google Scholar : PubMed/NCBI
13	Liu QS, Luo XY, Jiang H, Xing Y, Yang MH, Yuan GH, Tang Z and Wang H: Salvia miltiorrhiza injection restores apoptosis of fibroblast-like synoviocytes cultured with serum from patients with rheumatoid arthritis. Mol Med Rep. 11:1476–1482. 2015. View Article : Google Scholar
14	Sugiyama R, Agematsu K, Migita K, Nakayama J, Mokuda S, Ogura F, Haraikawa K, Okumura C, Suehiro S, Morikawa S, et al: Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations. Mol Biol Rep. 41:545–553. 2014. View Article : Google Scholar
15	Beaulieu E, Green L, Elsby L, Alourfi Z, Morand EF, Ray DW and Donn R: Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin. Clin Exp Immunol. 163:178–188. 2011. View Article : Google Scholar :
16	Gupta A, Niger C, Buo AM, Eidelman ER, Chen RJ and Stains JP: Connexin43 enhances the expression of osteoarthritis-associated genes in synovial fibroblasts in culture. BMC Musculoskelet Disord. 15:4252014. View Article : Google Scholar : PubMed/NCBI
17	Snead NM and Rossi JJ: RNA interference trigger variants: Getting the most out of RNA for RNA interference-based therapeutics. Nucleic Acid Ther. 22:139–146. 2012.PubMed/NCBI
18	Nishioka N, Matsuoka T, Yashiro M, Hirakawa K, Olden K and Roberts JD: Plasminogen activator inhibitor 1 RNAi suppresses gastric cancer metastasis in vivo. Cancer Sci. 103:228–232. 2012. View Article : Google Scholar
19	Jung HS and Shin YK: The potential RNAi-based combination therapeutics. Arch Pharm Res. 34:1–2. 2011. View Article : Google Scholar : PubMed/NCBI
20	Stornaiuolo M, La Regina G, Passacantilli S, Grassia G, Coluccia A, La Pietra V, Giustiniano M, Cassese H, Di Maro S, Brancaccio D, et al: Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents. J Med Chem. 58:2135–2148. 2015. View Article : Google Scholar : PubMed/NCBI
21	Siddiqui WA, Ahad A and Ahsan H: The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
22	Afonin KA, Grabow WW, Walker FM, Bindewald E, Dobrovolskaia MA, Shapiro BA and Jaeger L: Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat Protoc. 6:2022–2034. 2011. View Article : Google Scholar : PubMed/NCBI
23	Mysara M, Garibaldi JM and Elhefnawi M: MysiRNA-designer: A workflow for efficient siRNA design. PLoS One. 6:e256422011. View Article : Google Scholar : PubMed/NCBI
24	Hefferon KL: Innovations in siRNA research: A technology comes of age. Recent Pat Antiinfect Drug Discov. 5:226–239. 2010. View Article : Google Scholar : PubMed/NCBI
25	Wang Y, Li Z, Han Y, Liang LH and Ji A: Nanoparticle-based delivery system for application of siRNA in vivo. Curr Drug Metab. 11:182–196. 2010. View Article : Google Scholar : PubMed/NCBI
26	Sarret P, Doré-Savard L and Beaudet N: Direct application of siRNA for in vivo pain research. Methods Mol Biol. 623:383–395. 2010. View Article : Google Scholar : PubMed/NCBI
27	Yuan S, Wu B, Yu Z, Fang J, Liang N, Zhou M, Huang C and Peng X: The mitochondrial and endoplasmic reticulum pathways involved in the apoptosis of bursa of Fabricius cells in broilers exposed to dietary aflatoxin B₁. Oncotarget. 7:65295–65306. 2016.PubMed/NCBI
28	Zhang W: Research of the pathogensis of oxygen free radicals-mitochondrion pathway in oligospermia and asthenospermia. Chinese doctoral dissertation full text database. May;2015.